Sep 3, 2025 • 7:30 AM EDT XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference
Aug 20, 2025 • 8:49 AM EDT Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
Aug 13, 2025 • 7:30 AM EDT XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements
Upcoming Event Sep 8, 2025 • 9:00 am EDT H.C. Wainwright 27th Annual Global Investment Conference View Event Add to Calendar View All
